SCI Pharmtech, Inc. (TPE:4119)
48.95
-1.85 (-3.64%)
Nov 10, 2026, 1:30 PM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 5.85 billion as of November 9, 2026. It is the 21,137th most valuable company in the world and the 960th biggest in Taiwan. Its market cap has decreased by 12.90% in one year.
Market Cap
5.85B
Enterprise Value
6.83B
Revenue
1.26B
Global Rank
Country Rank
#960 Taiwan
PE Ratio
97.82
ChartMarket Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 5.85B, an increase of 449.41%. That is a compound annual growth rate of 7.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 5.85B | 0.51% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 11.93B |
| Foresee Pharmaceuticals | 11.64B |
| Standard Chemical & Pharmaceutical | 9.85B |
| Orient Pharma | 5.48B |
| Formosa Laboratories | 5.38B |
| Alar Pharmaceuticals | 5.11B |
| Yoda Pharmaceuticals | 4.84B |
| LIWANLI Innovation | 4.50B |